Table 1.

Existing literature around textbook outcome in hepatopancreatobiliary surgery

Ref.	Study period	Database	Indication	Components of TO	TO rates
Merath et al[3], 2019	2013-2015	Medicare	Benign and malignant hepatopancreatic lesions	No complications. No prolonged LOS. No 90-d mortality. No 90-d readmission	44.0%
Merath et al[4], 2020	1993-2015	Multi-institutional ICC database	Intrahepatic cholangiocarcinoma	R0 resection No transfusion. No complications. No prolonged LOS. No 30-d mortality. No 30-d readmission	25.5%
Tsilimigras et al[5], 2020	2000-2015	Multi-institutional HCC database	Hepatocellular carcinoma	R0 resection No reoperation. No complications (Clavien-Dindo ≥ III) No prolonged LOS. No 90-d mortality. No 90-d readmission	62.3%
Heidsma et al[15], 2020	2000-2016	US Neuroendocrine Tumor Study Group database	Pancreatic neuroendocrine tumors	R0 resection No complications (Clavien-Dindo ≥ III). No prolonged LOS. No 90-d mortality. No 90-d readmission	49.3%

TO: Textbook outcome; LOS: Length of stay; ICC: Intrahepatic cholangiocarcinoma; US: Ultrasonography; HCC: Hepatocellular carcinoma.